Prosight Management LP Grows Stock Holdings in Select Medical Holdings Corporation $SEM

Prosight Management LP grew its position in Select Medical Holdings Corporation (NYSE:SEM) by 147.3% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 874,915 shares of the health services provider’s stock after buying an additional 521,095 shares during the period. Select Medical accounts for about 2.6% of Prosight Management LP’s portfolio, making the stock its 19th largest position. Prosight Management LP owned approximately 0.71% of Select Medical worth $11,234,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the company. iSAM Funds UK Ltd acquired a new stake in Select Medical in the third quarter valued at approximately $96,000. Comerica Bank lifted its holdings in shares of Select Medical by 12.2% during the 3rd quarter. Comerica Bank now owns 90,976 shares of the health services provider’s stock valued at $1,168,000 after purchasing an additional 9,918 shares during the last quarter. Vise Technologies Inc. boosted its position in shares of Select Medical by 14.4% in the 3rd quarter. Vise Technologies Inc. now owns 20,045 shares of the health services provider’s stock worth $257,000 after purchasing an additional 2,519 shares in the last quarter. Entropy Technologies LP purchased a new position in Select Medical during the 3rd quarter worth $177,000. Finally, Invesco Ltd. increased its position in Select Medical by 9.4% during the 3rd quarter. Invesco Ltd. now owns 1,526,640 shares of the health services provider’s stock valued at $19,602,000 after buying an additional 131,435 shares in the last quarter. Institutional investors own 89.48% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the company. Wall Street Zen cut Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, March 9th. Zacks Research downgraded shares of Select Medical from a “hold” rating to a “strong sell” rating in a report on Thursday, February 26th. Royal Bank Of Canada reiterated a “sector perform” rating and issued a $16.50 target price (down from $19.00) on shares of Select Medical in a research note on Tuesday, March 3rd. Benchmark downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Wednesday, March 4th. Finally, Weiss Ratings upgraded shares of Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, February 20th. Two investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $15.63.

Select Medical Stock Performance

SEM opened at $16.25 on Friday. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.89. Select Medical Holdings Corporation has a 12-month low of $11.65 and a 12-month high of $18.60. The firm has a 50 day moving average of $15.53 and a two-hundred day moving average of $14.39. The firm has a market capitalization of $2.01 billion, a PE ratio of 14.13, a P/E/G ratio of 0.93 and a beta of 1.22.

Select Medical (NYSE:SEM) last released its quarterly earnings data on Thursday, February 19th. The health services provider reported $0.16 earnings per share for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.07). Select Medical had a return on equity of 7.26% and a net margin of 2.68%.The business had revenue of $1.40 billion during the quarter, compared to analyst estimates of $1.36 billion. During the same quarter in the previous year, the company earned $0.18 EPS. The firm’s revenue was up 6.4% compared to the same quarter last year. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. On average, analysts anticipate that Select Medical Holdings Corporation will post 1.17 EPS for the current year.

Select Medical Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 12th. Shareholders of record on Monday, March 2nd were given a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a yield of 1.5%. The ex-dividend date of this dividend was Monday, March 2nd. Select Medical’s dividend payout ratio (DPR) is currently 21.74%.

Select Medical announced that its Board of Directors has approved a share repurchase program on Thursday, February 19th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the health services provider to buy up to 49.5% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s leadership believes its shares are undervalued.

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.